TCM
CYTK icon

Texan Capital Management’s Cytokinetics CYTK Stock Holding History

Texan Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-23,268
Closed -$221K – 138
2014
Q1 		$221K Buy
23,268
+3,091
+15% +$28K 0.1% 134
2013
Q4 		$131K Sell
20,177
-876
-4% -$5.75K 0.07% 137
2013
Q3 		$159K Sell
21,053
-166
-0.8% -$1.78K 0.08% 150
2013
Q2 		$245K Buy
+21,219
New +$167K 0.12% 133

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Texan Capital Management's CYTK Position: Q2 2014 in Review

Texan Capital Management sold out of Cytokinetics (CYTK) in Q2 2014, closing a stake of 23,268 shares — an estimated $221K sold.

Texan Capital Management first reported a position in CYTK in Q2 2013 and held it in 4 quarters. The position peaked at $245K in Q2 2013. 89 funds tracked by Wall St. Rank hold CYTK as of Q2 2014.

  • Texan Capital Management reported no remaining Cytokinetics position as of Q2 2014 after selling out during the quarter.
  • Texan Capital Management sold 23,268 Cytokinetics shares in Q2 2014, an estimated $221K.
  • Texan Capital Management first reported a position in Cytokinetics in Q2 2013 and held it in 4 quarters.
  • Texan Capital Management's Cytokinetics position peaked at $245K in Q2 2013.
  • 89 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2014.

Based on Texan Capital Management's 13F filing for Q2 2014, filed 30 Jul 2014.